The Bracco Group is an Italian multinational active in the healthcare sector with more than 3,300 employees worldwide,[2] which operates in a variety of business areas.

[3] The Group is present in 100 countries and invests approximately 10% of its core diagnostic imaging revenues in research and innovation.

In Italy Bracco is also a brand associated with a number of historic pharmaceutical products such as Cebion, Xamamina, Euclorina, the Alfa eye-drops line and the Friliver range of sport supplements.

A chemistry graduate from the University of Pavia, Diana Bracco is also Chairman of Expo 2015 Spa, General Section Commissioner for the Italy Pavilion at Expo and Confindustria Vice President for Research & Innovation.

[9] The Bracco group has 1,800 patents, 7 research and development centers and 9 factories worldwide.

In 1934 Fulvio Bracco, Elio's son, officially joined the company which, the same year, began marketing Cebion, an innovative product based on vitamin C, recently discovered by the Hungarian biochemist Albert Szent-Györgyi.

In the second half of the 1980s, Bracco Spa became the leading international producer of non-ionic contrast agents.